Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00657631 · ClinicalTrials.gov registry record · NA

Acceptance and Commitment Therapy for Delusions

A NA study, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
4
Enrollment target

NCT00657631: Completed NA study, sponsored by Weill Medical College of Cornell University.

NCT00657631 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00657631, a NA study, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

Symptoms of schizophrenia have historically been treatment resistant despite advances in psychopharmacology. Acceptance and Commitment Therapy (ACT) has been shown through some preliminary research to be effective with psychotic symptoms (Bach \& Hayes, 2002). ACT is considered part of the "third wave of CBT" along with Dialectical Behavior Therapy (DBT; Linehan, 1993) and Mindfulness-based Cognitive Therapy (MBCT; Segal, Williams, \& Teasdale, 2001). The target of change in ACT is acceptance of symptoms as experiences that a person can have without experiencing distress, and while living a life in accordance with one's values. The current study assessed the effectiveness of ACT (8 sessions) for delusions. Participants received treatment as usual throughout the study. The intervention followed the protocol of ACT described in Hayes, Strosahl and Wilson (1999) in which treatment will consist of building acceptance, willingness, and commitment to change, clarifying values, defusion of thoughts and feelings, as well as defusion of self. These therapeutic aims attempted to be achieved by the practice of various exercises in and out of session as well as the discussion of various metaphors within session. It was hypothesized that participants will exhibit decreased distress due to delusions, decreased delusional conviction and a reduction of overall anxiety levels from participants' baselines.

Interventions

  • BEHAVIORAL Acceptance and Commitment Therapy

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2008-04
Est. Completion 2009-06
Phase NA

What the finished NCT00657631 record still lists

NCT00657631 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Acceptance and Commitment Therapy is the first listed.

NCT00657631 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00657631 about?

NCT00657631 is a clinical study titled "Acceptance and Commitment Therapy for Delusions". Symptoms of schizophrenia have historically been treatment resistant despite advances in psychopharmacology. Acceptance and Commitment Therapy (ACT) has been shown through some preliminary research to be effective with psychotic symptoms (Bach \& Hayes, 2002). ACT is considered part of the "third wa...

What is the current status of trial NCT00657631?

This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2008-04. Estimated completion is 2009-06.

What interventions are being tested in trial NCT00657631?

The interventions under investigation include: Acceptance and Commitment Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00657631?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00657631's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00657631, the US trial registry maintained by the National Library of Medicine. NCT00657631 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.